Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in hearttransplant recipients
- 1 June 2002
- journal article
- Published by Elsevier BV in Transplantation Proceedings
- Vol. 34 (4), 1265-1268
- https://doi.org/10.1016/s0041-1345(02)02640-4
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- TACROLIMUS AS A RESCUE IMMUNOSUPPRESSANT AFTER HEART AND LUNG TRANSPLANTATION1Transplantation, 1998
- Routine Surveillance Endomyocardial Biopsy: Late Rejection After Heart TransplantationThe Annals of Thoracic Surgery, 1997
- Coronary artery stenting in cardiac allograft vascular diseaseAmerican Heart Journal, 1997
- The use of tacrolimus and mycophenolate mofetil after cardiac transplantationCurrent Opinion in Cardiology, 1997
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- Graft coronary vasculopathy in cardiac transplantation — evaluation of risk factors by multivariate analysisEuropean Journal of Cardio-Thoracic Surgery, 1996
- The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infectionJournal of General Virology, 1992
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992